Genetically-determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effect.
about
Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trialsCytochrome P450-2D6 Genotype Definition May Improve Therapy for Paroxysmal Atrial Fibrillation A Case of Syncope Following "Pill-in-the-Pocket" Quinidine plus Propafenone.Influence of CYP2D6-dependent metabolism on the steady-state pharmacokinetics and pharmacodynamics of metoprolol and nicardipine, alone and in combination.Induction of polymorphic 4'-hydroxylation of S-mephenytoin by rifampicinThe roles of CYP2D6 and stereoselectivity in the clinical pharmacokinetics of chlorpheniramine.Pharmacogenetics of drug-drug interaction and drug-drug-gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6.Clinical consequences of polymorphic drug oxidation.Quantitative prediction of cytochrome P450 (CYP) 2D6-mediated drug interactions.Propafenone: an effective agent for the management of supraventricular arrhythmias.Stereoselective genetically-determined interaction between chronic flecainide and quinidine in patients with arrhythmiasCharacterisation of (R/S)-propafenone and its metabolites as substrates and inhibitors of P-glycoprotein.Simultaneous determination of serum propafenone and its metabolites using high-performance liquid chromatography.Pharmacokinetic and pharmacodynamic interactions between diltiazem and quinidine.
P2860
Q28071256-B665AD6B-5F50-4D71-811C-ACCC3571F57CQ33168000-2B2AB74D-4BA6-4A4D-8060-2FD7D67E7EA3Q34345780-D1142160-E8AA-45DB-A6B5-1576C3F85BDBQ34357273-58A2EDA4-46BF-4BB0-B0E3-8B5110C85E18Q35803822-24D7BD4D-4664-4434-AF50-F4B4F9CD9FF2Q36365500-DBB53B66-1646-4A40-8450-FA58D491CD88Q37448263-470915E4-9AB7-44A7-99E4-CCB88914870CQ39730908-4B82453D-B62F-430D-9F97-388CE51BEDFDQ41087913-DD6E1F3D-4C31-49A9-A2A2-6E717F038ADFQ41940518-69B25777-2356-4559-8568-A5734A48132EQ42478456-3823007F-7512-4E07-B528-74CC8D4E11FFQ50000912-60E4D711-82F0-4534-AA1A-DD2C05BF6442Q51579932-79DF9A76-9CA4-4C33-B013-220557C7C473
P2860
Genetically-determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effect.
description
1989 nî lūn-bûn
@nan
1989 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Genetically-determined interac ...... in modulating net drug effect.
@ast
Genetically-determined interac ...... in modulating net drug effect.
@en
Genetically-determined interac ...... in modulating net drug effect.
@nl
type
label
Genetically-determined interac ...... in modulating net drug effect.
@ast
Genetically-determined interac ...... in modulating net drug effect.
@en
Genetically-determined interac ...... in modulating net drug effect.
@nl
prefLabel
Genetically-determined interac ...... in modulating net drug effect.
@ast
Genetically-determined interac ...... in modulating net drug effect.
@en
Genetically-determined interac ...... in modulating net drug effect.
@nl
P2093
P2860
P1476
Genetically-determined interac ...... in modulating net drug effect.
@en
P2093
H K Kroemer
R L Woosley
P2860
P304
P356
10.1111/J.1365-2125.1989.TB05391.X
P407
P577
1989-04-01T00:00:00Z